{"References": [{"title": "Cognitive Impairment in Schizophrenia: A Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138", "authors": "Mark J. Millan, Yves Agid, Martin Brüne, Edward T. Bullmore, Cameron S. Carter, Nicola S. Clayton, Richard Connor, Sabrina Davis, Bill Deakin, Robert J. DeRubeis, Bruno Dubois, Mark A. Geyer, Guy M. Goodwin, Philip Gorwood, Thérèse M. Jay, Markus Joëls, Isabelle M. Mansuy, Andreas Meyer-Lindenberg, Declan Murphy, Edmund Rolls, Bernd Saletu, Michael Spedding, John Sweeney, Miles Whittington, Lawrence J. Young", "journal": "Pharmacology & Therapeutics", "year": "2012", "volumes": "133", "first page": "1", "last page": "61", "DOI": "10.1016/j.pharmthera.2011.09.002"}, {"title": "Glutamatergic Theories of Schizophrenia", "authors": "Daniel C. Javitt", "journal": "Israel Journal of Psychiatry and Related Sciences", "year": "2010", "volumes": "47", "first page": "4", "last page": "16", "DOI": ""}, {"title": "Cognitive Dysfunction in Schizophrenia: Convergence of γ-Aminobutyric Acid and Glutamate Alterations", "authors": "John H. Krystal, Deepak C. D'Souza, Daniel Mathalon, Erin Perry, Aysenil Belger, Robert Hoffman", "journal": "Archives of Neurology", "year": "2003", "volumes": "60", "first page": "1385", "last page": "1392", "DOI": "10.1001/archneur.60.10.1385"}, {"title": "Mismatch Negativity in Schizophrenia: A Meta-Analysis", "authors": "Michał Erickson, Alison Ruffle, James Gold", "journal": "Schizophrenia Research", "year": "2016", "volumes": "176", "first page": "261", "last page": "269", "DOI": "10.1016/j.schres.2016.06.026"}, {"title": "The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue", "authors": "Ralf Brisch, Arthur Saniotis, Rainer Wolf, Hendrik Bielau, Hans-Gert Bernstein, Johann Steiner, Bernhard Bogerts, Katharina Braun, Zbigniew Jankowski, Jaliya Kumaratilake, Maciej Henneberg, Tomasz Gos", "journal": "Frontiers in Psychiatry", "year": "2014", "volumes": "5", "first page": "47", "last page": "", "DOI": "10.3389/fpsyt.2014.00047"}, {"title": "Cognitive Dysfunction in Psychiatric Disorders: Characteristics, Causes and the Quest for Improved Therapy", "authors": "Mark J. Millan, Yves Agid, Martin Brüne, Edward T. Bullmore, Cameron S. Carter, Nicola S. Clayton, Richard Connor, Sabrina Davis, Bill Deakin, Robert J. DeRubeis, Bruno Dubois, Mark A. Geyer, Guy M. Goodwin, Philip Gorwood, Thérèse M. Jay, Markus Joëls, Isabelle M. Mansuy, Andreas Meyer-Lindenberg, Declan Murphy, Edmund Rolls, Bernd Saletu, Michael Spedding, John Sweeney, Miles Whittington, Lawrence J. Young", "journal": "Nature Reviews Drug Discovery", "year": "2012", "volumes": "11", "first page": "141", "last page": "168", "DOI": "10.1038/nrd3628"}, {"title": "NMDA Receptor Function in Large-Scale Anticorrelated Neural Systems with Implications for Cognition and Schizophrenia", "authors": "Alan Anticevic, Grega Repovs, John H. Krystal, Deanna M. Barch", "journal": "Proceedings of the National Academy of Sciences", "year": "2012", "volumes": "109", "first page": "16720", "last page": "16725", "DOI": "10.1073/pnas.1208494109"}, {"title": "Cognitive Impairment in Schizophrenia: Characteristics, Assessment and Treatment", "authors": "Philip D. Harvey", "journal": "Cambridge University Press", "year": "2013", "volumes": "", "first page": "", "last page": "", "DOI": "10.1017/CBO9781139003872"}, {"title": "Glutamate and Dopamine in Schizophrenia: An Update for the 21st Century", "authors": "Daniel C. Javitt", "journal": "Journal of Clinical Investigation", "year": "2007", "volumes": "117", "first page": "3076", "last page": "3083", "DOI": "10.1172/JCI31773"}, {"title": "Cognitive Enhancement in Schizophrenia: Pharmacological and Cognitive Remediation Approaches", "authors": "Christopher R. Bowie, Alice Medalia", "journal": "Psychiatric Clinics of North America", "year": "2016", "volumes": "39", "first page": "597", "last page": "611", "DOI": "10.1016/j.psc.2016.07.004"}]}